Please use this identifier to cite or link to this item:
/library/oar/handle/123456789/139554| Title: | Monotherapy versus dual lipid lowering therapy in high risk coronary artery disease patients |
| Authors: | Spiteri, Shanice Wirth, Francesca Gauci, Marilyn Desira, Josette Abela, Mark Xuereb, Robert G. Cassar Maempel, Andrew Camilleri, Liberato Azzopardi, Lilian M. |
| Keywords: | Coronary heart disease -- Treatment Coronary heart disease -- Patients Coronary artery disease -- Treatment Antilipemic agents -- Therapeutic use Statins (Cardiovascular agents) |
| Issue Date: | 2025 |
| Publisher: | University of Malta. Department of Pharmacy |
| Citation: | ³§±è¾±³Ù±ð°ù¾±,³æ20;³§.,³æ20;°Â¾±°ù³Ù³ó,³æ20;¹ó.,³æ20;³Ò²¹³Ü³¦¾±,³æ20;²Ñ.,³æ20;¶Ù±ð²õ¾±°ù²¹,³æ20;´³.,³æ20;´¡²ú±ð±ô²¹,³æ20;²Ñ.,³æ20;³Ý³Ü±ð°ù±ð²ú,³æ20;¸é.³æ20;³Ò.,…A³ú³ú´Ç±è²¹°ù»å¾±,³æ20;³¢.³æ20;²Ñ.³æ20;(2025).³æ20;²Ñ´Ç²Ô´Ç³Ù³ó±ð°ù²¹±è²â³æ20;±¹±ð°ù²õ³Ü²õ³æ20;»å³Ü²¹±ô³æ20;±ô¾±±è¾±»å³æ20;±ô´Ç·É±ð°ù¾±²Ô²µ³æ20;³Ù³ó±ð°ù²¹±è²â³æ20;¾±²Ô³æ20;³ó¾±²µ³ó³æ20;°ù¾±²õ°ì³æ20;³¦´Ç°ù´Ç²Ô²¹°ù²â³æ20;²¹°ù³Ù±ð°ù²â³æ20;»å¾±²õ±ð²¹²õ±ð³æ20;±è²¹³Ù¾±±ð²Ô³Ù²õ.³æ20;±Ê´Ç²õ³Ù±ð°ù³æ20;²õ±ð²õ²õ¾±´Ç²Ô³æ20;±è°ù±ð²õ±ð²Ô³Ù±ð»å³æ20;²¹³Ù³æ20;³Ù³ó±ð³æ20;83°ù»å³æ20;¹ó±õ±Ê³æ20;°Â´Ç°ù±ô»å³æ20;°ä´Ç²Ô²µ°ù±ð²õ²õ³æ20;´Ç´Ú³æ20;±Ê³ó²¹°ù³¾²¹³¦²â³æ20;²¹²Ô»å³æ20;±Ê³ó²¹°ù³¾²¹³¦±ð³Ü³Ù¾±³¦²¹±ô³æ20;³§³¦¾±±ð²Ô³¦±ð²õ,³æ20;°ä´Ç±è±ð²Ô³ó²¹²µ±ð²Ô. |
| Abstract: | Introduction: European
Society of Cardiology guidelines for the management of dyslipidaemias
recommend dual therapy with a high intensity statin and ezetimibe if target
low density lipoprotein cholesterol, LDL-C 1 4 mmol/L) is not achieved with statin
monotherapy. Aim: To assess lipid lowering therapy and LDL-C levels in coronary artery disease (CAD) patients who underwent a cardiac intervention. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/139554 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Monotherapy versus dual lipid lowering therapy in high risk coronary artery disease patients 2025.pdf | 212.29 kB | Adobe PDF | View/Open | |
| Monotherapy_versus_dual_lipid-lowering_therapy_in_high-risk_coronary_artery_disease_patients_2025.pdf | 327.17 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.
